Positioning biologic agents in the treat
β
Stephen B. Hanauer
π
Article
π
2009
π
John Wiley and Sons
π
English
β 170 KB
One decade after the emergence of biologic therapy for Crohn's disease (CD), our treatment algorithms are beginning to change. Once reserved for patients with refractory disease, disease unresponsive to conventional therapies, or those requiring multiple courses of corticosteroids, there is increasi